Intermittent PI3Kδ inhibition sustains anti-tumour immunity and curbs irAEs
Simon Eschweiler(La Jolla Institute for Immunology), Christian H. Ottensmeier(University of Southampton), Greg Friberg(Amgen (United States)), D. Lifson Jeffrey(NIHR CRUK Experimental Cancer Medicine Centre), Oliver Wood(NIHR CRUK Experimental Cancer Medicine Centre), James McCaul(Queen Elizabeth University Hospital), Andrew Schache(University of Liverpool), Pandurangan Vijayanand(La Jolla Institute for Immunology), Yingcong Li(Institute of Psychology, Chinese Academy of Sciences), Martina Dicker(La Jolla Institute for Immunology), Monalisa Mondal(La Jolla Institute for Immunology), Allan Hackshaw(University College London), Emma V. King(Poole Hospital), Mitchell Kronenberg(La Jolla Institute for Immunology), Paul M. Loadman(University of Bradford), William Wilson(Cancer Research UK), Gary D Acton(Cancer Research UK), Richard Shaw(University of Liverpool), Ferhat Ay(La Jolla Institute for Immunology), Peter A. Brennan(Queen Alexandra Hospital), Lindsey Chudley(University of Liverpool), Hayley Simon(La Jolla Institute for Immunology), Klaus Okkenhaug(Babraham Institute), Bart Vanhaesebroeck(London Cancer), Joseph H. Davies(Poole Hospital), Claire Paterson(Beatson West of Scotland Cancer Centre), Ciro Ramírez-Suástegui(La Jolla Institute for Immunology), Grégory Seumois(La Jolla Institute for Immunology), Adrian von Witzleben(NIHR CRUK Experimental Cancer Medicine Centre), Louisa Essame(Cancer Research UK), Gareth J. Thomas(Cancer Research UK), Fiona Kelly(University of Auckland), Joseph J. Sacco(University of Liverpool), Gavin Halbert(University of Strathclyde), Nicola Dobbs(Cancer Research UK), Jaya Thomas(NIHR CRUK Experimental Cancer Medicine Centre), Rabindra Prasad Singh(Project Directorate on Foot and Mouth Disease), Katy J. McCann(NIHR CRUK Experimental Cancer Medicine Centre), Alice Wang(La Jolla Institute for Immunology), Elena Lopez-Guadamillas(Spanish National Cancer Research Centre), Terry M. Jones(J&S Studies), Ting-Fang Chou(Institute of Molecular Biology, Academia Sinica)
Cited by 91
Related Papers
First-Trimester or Second-Trimester Screening, or Both, for Down's Syndrome
|New England Journal of Medicine|2005|1.1k
Best practices for single-cell analysis across modalities
|Nature Reviews Genetics|2023|1k
Tracking the Response of Natural Killer T Cells to a Glycolipid Antigen Using Cd1d Tetramers
|The Journal of Experimental Medicine|2000|879
Overall Survival Benefit with Tebentafusp in Metastatic Uveal Melanoma
|New England Journal of Medicine|2021|869
Cancer classification using the Immunoscore: a worldwide task force
|Journal of Translational Medicine|2012|803